Stay updated on Aducanumab in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page
- Check2 days agoChange DetectedPublication details for 'Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials' were updated to include the Erratum and corrected bibliographic details. This is a bibliographic update in the Publications section and does not affect study design or results.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedExpanded the Locations section to include a comprehensive list of trial sites across multiple US states and international regions (e.g., Australia, Canada, Europe, and Asia). Several previous location groupings were removed.SummaryDifference3%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedPublication note updated to say publications are automatically filled from PubMed, and the page revision was updated to v3.3.2 (replacing v3.2.0).SummaryDifference0.0%

- Check52 days agoChange DetectedThe notice about government funding and potential data currency issues has been removed from the page; it previously stated that information may not be up to date and pointed users to opm.gov for status updates.SummaryDifference0.1%

- Check59 days agoChange DetectedTaiwan site entry updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704'.SummaryDifference0.0%

- Check66 days agoChange DetectedNo substantive changes to core study information were detected; the Study Details content and the list of locations appear unchanged between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.